Tali Voloshin

Publications

• Alternating Electric Fields (TTFields) in Combination with Paclitaxel Are Therapeutically Effective Against Ovarian Cancer Cells in Vitro and in Vivo
  International Journal of Cancer. Dec, 2016  |   Pubmed ID: 27561100
• Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells
  Scientific Reports. Dec, 2015  |   Pubmed ID: 26658786
• Blocking IL1β Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous Metastasis
  Molecular Cancer Therapeutics. Jun, 2015  |   Pubmed ID: 25887886
• Recruitment of Oligoclonal Viral-Specific T Cells to Kill Human Tumor Cells Using Single-Chain Antibody-Peptide-HLA Fusion Molecules
  Molecular Cancer Therapeutics. Jun, 2015  |   Pubmed ID: 25852061
• Alternating Electric Fields (tumor-treating Fields Therapy) Can Improve Chemotherapy Treatment Efficacy in Non-small Cell Lung Cancer Both in Vitro and in Vivo
  Seminars in Oncology. Oct, 2014  |   Pubmed ID: 25213867
• Anti-Bv8 Antibody and Metronomic Gemcitabine Improve Pancreatic Adenocarcinoma Treatment Outcome Following Weekly Gemcitabine Therapy
  Neoplasia (New York, N.Y.). Jun, 2014  |   Pubmed ID: 24957319
• Small but Mighty: Microparticles As Mediators of Tumor Progression
  Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. Aug, 2014  |   Pubmed ID: 24705797
• Tumor-derived Microparticles Induce Bone Marrow-derived Cell Mobilization and Tumor Homing: a Process Regulated by Osteopontin
  International Journal of Cancer. Jul, 2014  |   Pubmed ID: 24347266
• Differential Therapeutic Effects of Anti-VEGF-A Antibody in Different Tumor Models: Implications for Choosing Appropriate Tumor Models for Drug Testing
  Molecular Cancer Therapeutics. Jan, 2014  |   Pubmed ID: 24150126
• Lysyl Oxidase-like-2 Promotes Tumour Angiogenesis and is a Potential Therapeutic Target in Angiogenic Tumours
  Carcinogenesis. Oct, 2013  |   Pubmed ID: 23828904
• The Host Immunological Response to Cancer Therapy: An Emerging Concept in Tumor Biology
  Experimental Cell Research. Jul, 2013  |   Pubmed ID: 23518388
• Tumor-initiating Cells of Various Tumor Types Exhibit Differential Angiogenic Properties and React Differently to Antiangiogenic Drugs
  Stem Cells (Dayton, Ohio). Sep, 2012  |   Pubmed ID: 22782858
• Host Response to Short-term, Single-agent Chemotherapy Induces Matrix Metalloproteinase-9 Expression and Accelerates Metastasis in Mice
  Cancer Research. Nov, 2011  |   Pubmed ID: 21978934
• G-CSF Supplementation with Chemotherapy Can Promote Revascularization and Subsequent Tumor Regrowth: Prevention by a CXCR4 Antagonist
  Blood. Sep, 2011  |   Pubmed ID: 21685373
• The Angiogenic Profile of Colorectal Cancer Patients Following Open or Laparoscopic Colectomy
  Cancer Biology & Therapy. Oct, 2010  |   Pubmed ID: 20814248